查找临床试验
已按「脊髓性肌萎缩症」检索，对应国际通用词 spinal muscular atrophy
共找到 11 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步正在招募III 期中国有中心NCT07444476
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
United States、China
年龄 15 Years – 60 Years
Biogen
正在招募III 期中国有中心NCT07221669
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
United States、Australia、Brazil、Chile、China 等 7 国
年龄 0 Days – 42 Days
Biogen
正在招募III 期中国有中心NCT06971094
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
China
年龄 2 Years – 12 Years
GeneCradle Inc
正在招募I 期 / II 期中国有中心NCT06421831
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
China
年龄 2 Years – 不限
GeneCradle Inc
正在招募不适用中国有中心NCT03217578
Neonatal Spinal Muscular Atrophy (SMA) Screening
Taiwan
年龄 0 Weeks – 2 Weeks
Kaohsiung Medical University Chung-Ho Memorial Hospital
正在招募I 期 / II 期中国有中心NCT05824169
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
China
年龄 0 Months – 6 Months
GeneCradle Inc
正在招募I 期 / II 期中国有中心NCT07554924
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
China
年龄 不限 – 180 Days
Lanyue Biotech (Hangzhou) Co., Ltd.
正在招募不适用中国有中心NCT04174157
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
United States、Greece、Ireland、Israel、Japan 等 11 国
年龄 不限 – 不限
Novartis Pharmaceuticals
正在招募I 期 / II 期中国有中心NCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
United States、Australia、Brazil、Canada、China 等 12 国
年龄 18 Years – 不限
Novartis Pharmaceuticals
正在招募不适用中国有中心NCT07822711
Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
China
年龄 6 Years – 12 Years
Peking University Third Hospital
正在招募不适用中国有中心NCT04010604
A Registered Cohort Study on SMA
China
年龄 1 Week – 70 Years
Wan-Jin Chen